These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 8077307)

  • 1. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
    Hidaka A; Okajima F; Ban T; Kosugi S; Kondo Y; Kohn LD
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1164-9. PubMed ID: 8077307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of thyrotropin-induced iodide uptake in FRTL-5 cells by immunoglobulins containing blocking thyrotropin-receptor antibodies under NaCl-depleted conditions.
    Takeuchi R; Kasagi K; Hidaka A; Miyamoto S; Misaki T; Iida Y; Konishi J
    Eur J Endocrinol; 1995 Jan; 132(1):109-17. PubMed ID: 7850004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' immunoglobulin G stimulates iodothyronine 5'-deiodinating activity in FRTL-5 rat thyroid cells.
    Toyoda N; Nishikawa M; Horimoto M; Yoshikawa N; Mori Y; Yoshimura M; Masaki H; Tanaka K; Inada M
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1506-11. PubMed ID: 1971826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.
    Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulated iodide uptake in FRTL-5 cells preincubated with Graves' immunoglobulins in NaCl-free medium: a sensitive assay for thyroid-stimulating antibodies.
    Hidaka A; Kasagi K; Takeuchi R; Iida Y; Misaki T; Grollman EF; Konishi J
    Thyroid; 1994; 4(1):31-6. PubMed ID: 7914446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
    Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A
    J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
    Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD
    J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
    Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untreated Graves' but not remission Graves' immunoglobulin G preparations increase intracellular Ca2+ in FRTL-5 thyroid cells.
    Kuwabara A; Okajima F; Akiyama H; Kobayashi I; Kondo Y
    Endocr J; 1996 Oct; 43(5):457-67. PubMed ID: 8980884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor.
    Hoermann R; Spitzweg C; Poertl S; Mann K; Heufelder AE; Schumm-Draeger PM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
    Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of P1-purinergic agonist on thyrotropin stimulation of H2O2 generation in FRTL-5 and porcine thyroid cells.
    Björkman U; Ekholm R
    Eur J Endocrinol; 1994 Feb; 130(2):180-6. PubMed ID: 8130894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An adenosine derivative cooperates with TSH and Graves' IgG to induce Ca2+ mobilization in single human thyroid cells.
    Yanagita Y; Okajima F; Sho K; Nagamachi Y; Kondo Y
    Mol Cell Endocrinol; 1996 Apr; 118(1-2):47-56. PubMed ID: 8735590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
    Hidaka A; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1993 Oct; 196(1):187-95. PubMed ID: 8216292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
    Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
    Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.